IntiQuan AG

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

IntiQuan AG - overview

Established

2015

Location

Basel, -, Switzerland

Primary Industry

Business Support Services

About

Based in Basel, Switzerland, and founded in 2015, IntiQuan AG, a. k. a. IntiQuan, operates as a provider of consulting services that specializes in pharmacometrics and statistical modeling and simulation services for the biopharmaceutical sector.


In October 2024, Groupe ProductLife S. A. S. , a portfolio company of 21 Invest and Oakley Capital Private Equity, acquired IntiQuan AG.


As of October 2024, Stefan Wetzel is the CEO of the company. IntiQuan offers specialized services and software for pharmacometric modeling, clinical pharmacology, drug development, regulatory consulting, and computational workflows. The company’s pharmacometric modeling and simulation services support data-driven decision-making throughout drug development phases. The company's clinical pharmacology services explore drug effects relative to system concentrations, contributing to comprehensive development strategies.


IntiQuan also offers drug development services, which include guidance on study design, execution, and data interpretation for both nonclinical and clinical studies, while regulatory consulting ensures alignment with agency requirements. IntiQuan’s workflow solutions include IQ Desktop, a virtual modeling and simulation environment, and IQR Tools, an R-based platform for PK/PD analysis, facilitating reproducible, efficient, and compliant workflows.


Current Investors

Groupe ProductLife S.A.S.

Primary Industry

Business Support Services

Sub Industries

Consulting Services, Pharmaceutical Research & Development

Website

www.intiquan.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

IntiQuan AG - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedIntiQuan AG-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.